Magnesiumsulfat

Magnesium sulfate, the active ingredient in Magnesiumsulfat, is a mineral electrolyte presented as a sterile injectable solution for intravenous use. It is employed to correct magnesium deficiency and to manage obstetric and cardiac conditions where magnesium levels influence vascular tone and electrical stability. GNH USA supplies Magnesiumsulfat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate acts as a systemic magnesium repletion agent and influences neuromuscular and cardiovascular function. - Magnesium deficiency: restores normal serum magnesium concentrations and alleviates related neuromuscular symptoms. - Eclampsia: prevents and treats seizures in pregnant patients with severe pre‑eclampsia. - Pre‑eclampsia: stabilises blood pressure and reduces risk of progression to eclampsia. - Cardiac arrhythmias: corrects electrolyte‑related rhythm disturbances and supports anti‑arrhythmic therapy.

Adverse reactions may occur with intravenous magnesium sulfate administration.

Common Side Effects: - Flushing or feeling of warmth: transient vasodilatory sensation. - Nausea or vomiting: gastrointestinal upset. - Headache: mild to moderate intensity. - Hypotension: mild blood pressure reduction.

Serious or Rare Side Effects: - Respiratory depression: reduced respiratory drive, especially with high doses. - Cardiac arrest or severe bradycardia: profound conduction disturbances. - Hypermagnesemia: neuromuscular weakness, loss of deep tendon reflexes, and cardiac arrhythmias.

Magnesium sulfate requires careful clinical monitoring to avoid toxicity. - Renal impairment: adjust dose or avoid if severe renal failure is present. - Neuromuscular disease: monitor for exaggerated muscle weakness. - Cardiac conduction disorders: use with caution in patients with heart block. - Concomitant calcium channel blockers: increased risk of hypotension and bradycardia. - Serum magnesium monitoring: check levels regularly during prolonged therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Magnesium sulfate can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Neuromuscular blocking agents: potentiates muscle relaxation and may cause prolonged paralysis. - Calcium‑containing products: antagonistic effect can reduce therapeutic benefit.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: may increase risk of neuromuscular blockade. - Loop diuretics: can enhance magnesium loss, requiring closer monitoring. - ACE inhibitors or ARBs: additive hypotensive effect may occur.